A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases

NCT00554229 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

896

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: ZD4054
DRUG: Placebo

Sponsor

AstraZeneca